Arthneeti
VO

Valiant Organics Ltd

Q2 FY25Chemicals & Petrochemicals

Valiant Organics Ltd Q2 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book

Q2 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹411
Market cap₹1.2K Cr
P/E23.7
Updated24 Sept 2026
Read6 min read

Based on Valiant Organics Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q2-FY25 Revenue from Operations: - Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) - Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24) - Sales Volume: - Overall sales volume declined by 6% in Q2-FY25 (Page 10) - Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24: - Chlorination: 730 MT vs 894 MT - Hydrogenation: 479 MT vs 660 MT - Ammonolysis: 118 MT vs 136 MT - Others: 221 MT vs 348 MT - Outlook: - No explicit forward-looking revenue or volume guidance provided. Q2-FY25 Consolidated Financials (Page 9 & 12): - EBITDA: INR 24 Mn, down 84.5% YoY from INR 155 Mn - Operating EBITDA Margin: 1.5%, down 613 bps YoY from 7.63% - Profit After Tax (PAT): INR (125) Mn, compared to PAT of INR 47 Mn YoY (loss vs profit) - PAT Margin: (7.80)%, down significantly from 2.31% - Q2-FY25 Standalone Financials (Page 14): - EBITDA: INR 23 Mn, down 86.7% YoY from INR 173 Mn - Operating EBITDA Margin: 1.44%, down 804 bps YoY from 9.48% - PAT: INR (112) Mn, down from INR 39 Mn YoY (loss vs profit) - PAT Margin: (6.99)%, down from 2.14% - Explicit Margin Outlook: - The presentation does not state any explicit margin outlook or guidance for future periods.

From Valiant Organics Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2-FY25 Revenue from Operations:
  • Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24)
  • Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24)
  • Sales Volume:
  • Overall sales volume declined by 6% in Q2-FY25 (Page 10)
  • Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24:
  • Chlorination: 730 MT vs 894 MT
  • Hydrogenation: 479 MT vs 660 MT
  • Ammonolysis: 118 MT vs 136 MT
  • Others: 221 MT vs 348 MT
  • Outlook:

2 more points management made on revenue & sales performance

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not explicitly detail any specific capex amounts, capacity expansions, or new plant/projects with associated statuses and timelines. - The presentation provides the current manufacturing footprint, listing capacities by plant and product type (e.g., Chlorination - Sarigam: 18,000 MTPA, Hydrogenation - Jhagadia Unit 1: 27,000 MTPA, etc.) but does not mention any ongoing or planned capacity expansions. - There is no mention of new plant constructions or project commencements. - The financial statements and highlights do not disclose specific capital expenditure related to expansion or new projects. Therefore, based strictly on the provided presentation pages, no capex, capacity expansion, or new projects with defined amounts, status, or timelines are described.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem Ltd
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided investor presentation does not report any specific figures or details related to order book, order inflow, or pending orders. The slides and financials focus primarily on: - Revenue from operations - Financial performance metrics like EBITDA, PAT, and margins - Sales volumes across key chemistries

2 more points management made on order book & pipeline

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Valiant Organics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Himadri Speciality Chemical Ltd (Q2 FY25)

    1,135.21 Cr, up 13.01% YoY (Page 45) . Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q2 FY25 investor presentation — and how it ran

  • Vidhi Specialty Food Ingredients Ltd (Q2 FY25)

    Year-on-Year (Y-o-Y) growth: 13.9% (Page 8) . Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q2 FY25 investor presentation — an

  • Chemcon Speciality Chemicals Ltd (Q2 FY25)

    30% YoY). Key investor presentation takeaways from Chemcon Speciality Chemicals Ltd's Q2 FY25 investor presentation — and how it ranks against sector peers.

  • Excel Industries Ltd (Q2 FY25)

    Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore). Key investor presentation takeaways from Excel Industries Ltd's

Compare:vs Solar Industries India Ltdvs Pidilite Industries Ltdvs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Valiant Organics Ltd Q2 FY25 results?

Q2-FY25 Revenue from Operations: - Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) - Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24) - Sales Volume: - Overall sales volume declined by 6% in Q2-FY25 (Page 10) - Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24: - Chlorination: 730 MT vs 894 MT - Hydrogenation: 479 MT vs 660 MT - Ammonolysis: 118 MT vs 136 MT - Others: 221 MT vs 348 MT - Outlook: - No explicit forward-looking revenue or volume guidance provided. Q2-FY25 Consolidated Financials (Page 9 & 12): - EBITDA: INR 24 Mn, down 84.5% YoY from INR 155 Mn - Operating EBITDA Margin: 1.5%, down 613 bps YoY from 7.63% - Profit After Tax (PAT): INR (125) Mn, compared to PAT of INR 47 Mn YoY (loss vs profit) - PAT Margin: (7.80)%, down significantly from 2.31% - Q2-FY25 Standalone Financials (Page 14): - EBITDA: INR 23 Mn, down 86.7% YoY from INR 173 Mn - Operating EBITDA Margin: 1.44%, down 804 bps YoY from 9.48% - PAT: INR (112) Mn, down from INR 39 Mn YoY (loss vs profit) - PAT Margin: (6.99)%, down from 2.14% - Explicit Margin Outlook: - The presentation does not state any explicit margin outlook or guidance for future periods.

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Is Valiant Organics Ltd planning capital expenditure?

The investor presentation does not explicitly detail any specific capex amounts, capacity expansions, or new plant/projects with associated statuses and timelines.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.